Researchers Funded by the National MS Society Build on Commercial Partnership to Develop Diagnostic

A team of researchers from around the country have published findings indicating the accuracy of MSPrecise® (Amarantus Bioscience Holdings, Inc.), a laboratory test under development for diagnosing MS. The study was funded by the Society, the National Institutes of Health, the Burroughs Wellcome Fund and DioGenix, Inc. (since acquired by Amarantus). Previous work on MSPrecise was funded by the National MS Society through its commercial research arm, Fast Forward. William Rounds and Nancy Monson, PhD (University of Texas Southwestern Medical Center, Dallas) and colleagues report these findings in Gene…

Favicon of da :

Prosegui la lettura...
Traduci l'articolo...

Sclerosi Multipla News

Potrebbe interessarti anche

Argomenti correlati